Lee Han-Soo of Korean Biomedical Review reports that “researchers at St. Mary’s Hospital have discovered a method that can drastically increase the survivability of patients suffering from aplastic anemia, an intractable blood disease, the hospital said Monday.
Aplastic anemia is a disease in which the number of hematopoietic stem cells decreases and impairs the production of red blood and white blood cells and platelets. It causes anemia, serious infections, bleeding, and in severe cases can cause fatalities. The best treatment for the cure of severe aplastic anemia is allogeneic hematopoietic stem cell transplantation donated from siblings with a histocompatibility antigen (HLA) match. However, there is only a 25 percent chance of finding a sibling donor with an HLA match. As an alternative, hospitals perform transplantation from unrelated donors with HLA matching, but this has also proven difficult to find a suitable donor.”Source: Korea Biomedical Review